Leptin Enhances Synthesis of Proinflammatory Mediators in Human Osteoarthritic Cartilage—Mediator Role of NO in Leptin-Induced<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML"><mml:msub><mml:mtext>PGE</mml:mtext><mml:mn mathvariant="bold">2</mml:mn></mml:msub></mml:math>, IL-6, and IL-8 Production

Mediators of Inflammation - Tập 2009 - Trang 1-10 - 2009
Katriina Vuolteenaho1, Anna Koskinen1, Meiju Kukkonen1, Riina Nieminen1, Unto Päivärinta2, Teemu Moilanen2,1, Eeva Moilanen1
1The Immunopharmacology Research Group, Medical School, University of Tampere and Research Unit, Tampere University Hospital, 33014 University of Tampere, Tampere, Finland
2Coxa Hospital for Joint Replacement, P.O. Box 652, 33101, Tampere, Finland

Tóm tắt

Obesity is an important risk factor for osteoarthritis (OA) in weight-bearing joints, but also in hand joints, pointing to an obesity-related metabolic factor that influences on the pathogenesis of OA. Leptin is an adipokine regulating energy balance, and it has recently been related also to arthritis and inflammation as a proinflammatory factor. In the present paper, the effects of leptin on human OA cartilage were studied. Leptin alone or in combination with IL-1 enhanced the expression of iNOS and COX-2, and production of NO,PGE2, IL-6, and IL-8. The results suggest that the effects of leptin are mediated through activation of transcription factor nuclear factorκB (NF-κB) and mitogen-activated protein kinase (MAPK) pathway c-JunNH2-terminal kinase (JNK). Interestingly, inhibition of leptin-induced NO production with a selective iNOS inhibitor 1400 W inhibited also the production of IL-6, IL-8, andPGE2, and this was reversed by exogenously added NO-donor SNAP, suggesting that the effects of leptin on IL-6, IL-8, andPGE2production are dependent on NO. These findings support the idea of leptin as a factor enhancing the production of proinflammatory factors in OA cartilage and as an agent contributing to the obesity-associated increased risk for osteoarthritis.

Từ khóa


Tài liệu tham khảo

10.1038/372425a0

2005, The Journal of Immunology, 174, 3137, 10.4049/jimmunol.174.6.3137

10.1042/BJ20051578

2007, Cellular & Molecular Immunology, 4, 1

10.1080/03009740600991760

2003, Osteoarthritis: epidemiology and classification, 1781

10.1002/art.11303

10.1016/j.joca.2006.01.009

10.1016/j.joca.2007.01.018

2008, Clinical and Experimental Rheumatology, 26, 275

10.1006/bbrc.2001.5543

10.1002/art.10811

2005, Arthritis Research & Therapy, 7, R581, 10.1186/ar1708

10.1136/ard.2007.069377

2007, Scandinavian Journal of Rheumatology, 36, 247, 10.1080/03009740701483014

10.1053/joca.2001.0431

10.1124/pr.56.3.3

10.1097/01.blo.0000144854.66565.8f

1982, Analytical Biochemistry, 126, 131, 10.1016/0003-2697(82)90118-X

1976, Analytical Biochemistry, 72, 248, 10.1016/0003-2697(76)90527-3

10.1002/art.11315

10.1006/bbrc.1995.1003

1999, Journal of Rheumatology, 26, 2002

10.1016/0014-5793(94)00994-5

10.1006/bbrc.1994.1426

1995, Mediators of Inflammation, 4, 107, 10.1155/S0962935195000184

1997, Biochemical Journal, 324, 305, 10.1042/bj3240305

1995, American Journal of Pathology, 146, 75

10.1002/1529-0131(199807)41:7<1266::AID-ART18>3.0.CO;2-Y

10.1002/1529-0131(199902)42:2<248::AID-ANR6>3.0.CO;2-S

10.1016/S1063-4584(96)80009-4

10.1080/03009740310000355

2000, American Journal of Physiology, 279, C961, 10.1152/ajpcell.2000.279.4.C961

10.1016/j.joca.2004.04.003

10.1002/1529-0131(199807)41:7<1275::AID-ART19>3.0.CO;2-T

10.1002/1529-0131(200006)43:6<1290::AID-ANR11>3.0.CO;2-R

10.1002/art.10518

10.1053/joca.1999.0228

10.1038/sj.bjp.0704903

10.1152/ajpcell.00320.2004

10.1016/j.neulet.2005.11.022

10.1210/en.2006-0940

1997, Journal of Clinical Investigation, 99, 1231, 10.1172/JCI119280

2001, Journal of Rheumatology, 28, 2509

10.1155/MI.2005.249

10.1136/ard.2003.011742

10.1002/1529-0131(200009)43:9<1905::AID-ANR1>3.0.CO;2-P

10.1210/en.2006-0224

2000, Cytokines, Cellular and Molecular Therapy, 6, 71, 10.1080/13684730050515796

10.1053/joca.2001.0488

10.1016/S1063-4584(96)80012-4

1995, The Journal of Immunology, 154, 5418, 10.4049/jimmunol.154.10.5418

10.1016/S0945-053X(00)00111-6

10.2165/00063030-200418010-00003

10.1006/cimm.1999.1490

10.1016/S0015-0282(03)00776-3

2005, The Journal of Immunology, 174, 6820, 10.4049/jimmunol.174.11.6820

10.1016/S0898-6568(02)00006-2

10.1016/j.lfs.2007.09.007

10.1210/en.138.11.5055

10.1016/S0014-2999(99)00314-3

1999, Diabetes, 48, 903, 10.2337/diabetes.48.4.903

Thông tin
Thông tin xuất bản

Mediators of Inflammation

Tập 2009

1-10

Thông tin tác giả